KEESHA WYATT: Open Payments
NPI 1760994149 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 26 payments from 12 companies in 2025. Trend: 2023 $635 · 2024 $169 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $71 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Lilly USA, LLC | 3 | $48 |
| SANOFI-AVENTIS U.S. LLC | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| Astellas Pharma US Inc | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Exact Sciences Corporation | 2 | $31 |
Products named: SHINGRIX, JARDIANCE, TZIELD, Ozempic, MOUNJARO, Kerendia, Rybelsus, ZORYVE.
Industry payments across TX — which companies pay providers there.
